Biotechnology Stocks I Performance Guide: Tarsus Pharmaceuticals, Inc. (TARS)
TARS has no dividends.
Table and Chart of TARS Performance
See what a $1,000 investment in TARS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TARS Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $24.17 |
| End Date | May-10-2024 |
| End Price | $37.00 |
| # Prices | 43 |
| Min Date | Mar-31-2023 |
| Min Price | $12.57 |
| Max Date | Dec-31-2020 |
| Max Price | $41.33 |
| Total Return | 53.08% |
| Annualized Return | 12.62% |
| Current Value of $1,000 Purchase | $1,531 |
| Number Returns | 903 |
| Average Return | 0.46% |
| Number Profitable Returns | 343 |
| Percent Profitable Returns | 37.98% |
| Number Unprofitable Returns | 560 |
| Percent Unprofitable Returns | 62.02% |
| Profitable to Unprofitable Returns Ratio | 0.61 |
| TARS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,397,923,000 |
| Beta | 1.109 | Price to Sales | 77.74 |
| Earnings per Share | $-4.7500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.9 |
| PRICE DATA | |
| 52 Week High | $42.5 |
| 52 Week Low | $12.57 |
| Analyst Target Price | $56.63 |
| 50-Day Moving Average | $34.25 |
| 200-Day Moving Average | $23.39 |
| FINANCIAL DATA | |
| Revenue per Share | $1.35 |
| Revenue | $42,561,000 |
| Profit Margin | 0% |
| Return on Equity | -66.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TARS Compare Returns with S&P 500
TARS Trendline Chart
TARS Moving Average Chart
TARS Stock Return Map - See Patterns of Gains and Losses
TARS Stock Returns/Purchase Dates